Delayed Meniere Disease Tied to Higher Prevalence of Bilateral Disease

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Oct 31, 2024.

By Lori Solomon HealthDay Reporter

THURSDAY, Oct. 31, 2024 -- Delayed Meniere disease (DMD) is associated with a higher prevalence of bilateral Meniere disease (MD) compared with classic MD (CMD), according to a study published online Oct. 15 in the European Archives of Oto-Rhino-Laryngology.

Suming Shi, from the Affiliated Eye and ENT Hospital at Fudan University in Shanghai, and colleagues investigated the clinical characteristics and endolymphatic hydrops manifestations in patients with DMD versus CMD. The analysis included 523 patients diagnosed with MD.

The researchers found that DMD prevalence was 6.1 percent. In DMD, bilateral MD was significantly more common (34.4 versus 14.5 percent). There was also more severe hearing loss in the first involved ear and more deteriorated vestibular-evoked myogenic potential in the contralateral ear among DMD patients. All affected ears had endolymphatic hydrops, with a higher contralateral endolymphatic hydrops proportion in DMD (34.4 versus 15.0 percent).

"DMD patients exhibit a higher prevalence of bilateral MD, more severe hearing loss, and greater contralateral endolymphatic hydrops compared to CMD patients," the authors write. "Both subtypes share similar endolymphatic hydrops characteristics, suggesting common underlying mechanisms."

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-11-01 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords

AI Assitant